2019年 参加者
• Senior Project Leader, Ablynx a Sanofi Co
• VP Cellular Immunology, Agenus Inc
• Scientist, Agenus Switzerland Inc
• Scientist, Agenus UK Ltd
• Senior Scientist, Alligator Bioscience AB
• Director, Alligator Bioscience AB
• CTO, Altimmune UK Ltd
• Director Research & Early Development Lead Oncology, Amgen Research Munich GmbH
• CEO & COO & CSO, Antikor Biopharma Ltd
• CSO & Executive VP & Founder, Aratinga Bio Inc
• Founder & CEO, Aratinga Bio Inc
• Senior Scientist, Ardigen SA
• Business Development Manager, Ardigen SA
• Research Fellow, Astellas Pharma Inc
• Principal Scientist, AstraZeneca
• Director Oncology Research, AstraZeneca
• Associate Director Translational Sciences, AstraZeneca
• Assay Scientist, Avacta Life Sciences Ltd
• Instructor, Beth Israel Deaconess Medical Center
• Product Manager, Bio Techne Ltd
• Senior VP & CSO & Managing Director, BioAgilytix Europe
• Researcher, BIOCAD
• Scientist, BIOCAD
• Medical Director Medical Affairs, BIOCAD
• Director, Biocytogen
• Business Development Manager, Biocytogen
• Marketing Associate, Biocytogen Boston Corp
• Project Leader, Biologie Servier
• CSO, Biomunex Pharmaceuticals
• Senior VP & Head, Bristol Myers Squibb Co
• VP Scientific Operations, Caprion Biosciences Inc
• Professor of Immunology, Cardiff University
• Professor, Catholic University of Korea
• Senior Process Development Scientist, Cell & Gene Therapy Catapult
• Chief Clinical Officer, Cell & Gene Therapy Catapult
• Head, Cell & Gene Therapy Catapult
• Chairman & CEO, Cellectis Inc
• Director, Celyad
• Global Head, Celyad Inc
• Graduate Student, Charite University of Medicine
• Professor, Chungnam Natl University
• Senior Editor, Clarivate Analytics
• Associate Director, CMED Grp UK
• CEO, Cordes Biotech AS
• Senior Director Non Clinical Safety, Covagen AG
• Head, CRISPR Therapeutics
• VP Global Quality & Scientific Excellence, Crown Bioscience Inc
• Director Business Development, Definiens AG
• Scientist, Definiens AG
• Director Sales & Business Development, Definiens AG
• VP Business Development, Discovery Life Sciences Inc
• CEO, DNAtrix Inc
• Professor, Dublin City University
• Senior Editor, EBioMedicine
• CEO & CSO, Elasmogen Ltd
• Full Professor, ETH Zurich
• Senior Scientist, F Hoffmann La Roche AG
• Scientist, F star Biotechnology Ltd
• Research Associate, F star Biotechnology Ltd
• VP Business Development, FIMECS Inc
• Senior Research Scientist, Fred Hutchinson Cancer Research Ctr
• Lead Scientist, GE Healthcare UK Ltd
• Principal Scientist, Genentech Inc
• Manager, Genetic Engineering & Biotechnology News
• Corporate VP, Genmab
• Senior Scientist, Genmab BV
• VP Transgenic Technologies, genOway
• Group Leader, German Cancer Research Ctr DKFZ
• Group Leader Medical & Translational Oncology, German Cancer Research Ctr DKFZ
• Expert Scientist, GlaxoSmithKline
• Scientific Leader, GlaxoSmithKline
• Scientist, GLYCOTOPE GmbH
• Director & Professor, Gustave Roussy Institute
• Head, Hadassah Hebrew Univ Hospital
• Director Business Development, Harbour BioMed
• Graduate Student, Hebrew University Jerusalem
• Clinical Professor & Director Cancer Immune Therapy, Herlev Hospital
• Founder & CEO & Managing Director, HOT Screen GmbH
• Lab Head Advanced Cell Models Lab, iBET Instituto de Biologia Experimental Tecnologica
• Professor, Icahn School of Medicine at Mount Sinai
• Medical Science Liaison, Idera Pharmaceuticals Inc
• Field Medical Manager, Idera Pharmaceuticals Inc
• Project Leader, Idorsia Pharmaceuticals Ltd
• CMO, IGM Biosciences Inc
• Senior Scientist & Head, Immuneed AB
• COO, Immuneed AB
• Business Development, Immuneed AB
• Head, Immunocore Ltd
• Founder & CTO, ImmunXperts SA
• Co Founder, Individual Consultant
• Professor, Inje University
• CEO & CMO, INmuneBio Inc
• Engineer, Innate Pharma
• Manager, Innate Pharma
• Director Sales, INOVOTION
• Head, Institut Curie
• Professor, Institute of Cancer Research
• CEO, IntoCell
• Director, Invus SAS
• Analyst, Invus SAS
• Head, IO Biotech ApS
• Associate Director, IsoPlexis
• European Sales Manager, IsoPlexis
• Director European Sales, IsoPlexis
• Research Scientist, iTeos Therapeutics SA
• Director Europe Business Development, Jackson Lab
• VP External Research & Business Development, Kadmon Holdings Inc
• Student, KAIST
• Head Gene & Cell Therapy Grp, Karolinska Institute
• Reader & Head Cancer Antibody Discovery, Kings College London
• Senior PostDoc Scientist, Kings College London
• Graduate Student, Kingston University
• Professor & Director, Klinikum Darmstadt
• VP Immuno Oncology, Kymab Ltd
• Science & Business Liaison, Legend Biotech Ireland Ltd
• Global Head, Lonza Cologne GmbH
• CSO & Director Project Mgmt, MaSTherCell
• Assistant Professor, Mayo Clinic & Foundation
• Surgical Oncologist & Associate Professor, Mayo Clinic & Foundation
• Director Preclinical Studies, Medicago Inc
• Head, Medigene AG
• Executive Medical Dir & Head of Companion Diagnostics, Merck & Co Inc
• Scientist, Merck KGaA
• Account Manager, Merck Millipore UK Ltd
• Senior VP Global Clinical Development & CMO, Merck Research Labs
• Director, MERCK SHARP & DOHME
• Scientific Liaison, Merck Sharp & Dohme Sweden AB
• Senior Medical Assessor, MHRA
• Senior Non Clinical Assessor, MHRA
• Business Development & Program Manager, MI mAbs
• Product Manager, MilliporeSigma
• Principal R&D Scientist, MilliporeSigma
• CEO, multimmune GmbH
• Professor, Natl Univ of Quilmes
• Senior Scientist, Nektar Therapeutics Inc
• Scientist, Nouscom SRL
• Lab Head, Novartis Institutes for BioMedical Research
• Global Program Medical Director, Novartis Pharma AG
• Scientist, NovImmune SA
• CEO & Advisor, nxt2b
• Program Director Discovery, Oncodesign SA
• Lab Director Cellular Pharmacology, Oncodesign SA
• Research Tech, Oslo University Hospital
• Postdoc Fellow, Oslo University Hospital
• Engineer, Oslo University Hospital
• Graduate Student, Oslo University Hospital
• Senior Scientist, Ottawa Health Research Institute
• Lab Head, Peter MacCallum Cancer Ctr
• Director In Vivo Pharmacology & Oncology, Pfizer Inc
• Associate Professor, Prince of Wales Hospital
• Immunology Sales Specialist, ProImmune Ltd
• Principal Scientist, Prokarium
• Project Leader, Protisvalor
• CEO, PsiOxus Therapeutics Ltd
• Head, PsiOxus Therapeutics Ltd
• Director Sales, RareCyte Inc
• Assoc Dir Immune & Inflammatory Diseases, Regeneron Pharmaceuticals Inc
• PostDoc Fellow, Regeneron Pharmaceuticals Inc
• Senior Staff Scientist, Regeneron Pharmaceuticals Inc
• CEO & Founder, Replimune Ltd
• Molecular Biologist, RGCC Intl GmbH
• Head Functional Characterization, Roche Innovation Ctr Penzberg
• Head, Roche Innovation Ctr Zurich
• Head of Oncology Discovery Pharmacology, Roche Innovation Ctr Zurich
• Senior Scientist, Roche Innovation Ctr Zurich
• Team Leader, Roche Innovation Ctr Zurich
• Head of Research, San Raffaele Scientific Institute
• Associate Professor, Southampton General Hospital
• Professor, St Georges Hospital
• Founder & CEO, Straximm Therapeutics Inc
• Founder & CSO, Straximm Therapeutics Inc
• Project Director, Symphogen AS
• Senior Researcher, Sysmex Corp
• Sr Sci, SystImmune Inc
• CEO, SystImmune Inc
• Associate Professor, Taipei Medical Univ
• CMO & Head, Targovax ASA
• Student, Technical University Munich
• Senior Product Mgr, Thermo Fisher Scientific
• Founder & CEO, TILT Biotherapeutics Ltd
• Exec VP Pharmaceutical R&D, Tocagen
• Project Manager, Trans Hit Biomarkers Inc
• CSO & Executive VP R&D, Transgene SA
• Sales Manager, Ultivue Inc
• Sales & Marketing Director, Ultivue Inc
• Clinical Research Training Fellow, University College London
• Professor, University Hospital Tuebingen
• Group Leader, University Medical Ctr Freiburg
• Professor & Head, University Medical Ctr Groningen
• Adjunct Professor, University of Bologna
• Director Immunopeptidomics, University of Lausanne
• Prof Medical Sciences, University of Manchester
• Predoctoral, University of Milan
• Professor, University of Oxford
• Assistant Professor, University of Pittsburgh
• Chair Gene Immunotherapy, University of Regensburg
• Graduate Student, University Of Sheffield
• Associate Professor Oncology, University of Southampton
• Senior PostDoc Research Fellow Antibody & Vaccine Group, University of Southampton
• Head & Professor, University of Tuebingen
• PostDoc, University of Wuerzburg
• Expert, Uppsala Monitoring Ctr
• Chief Development Officer, Urosphere SAS
• Associate Professor, Utrecht University
• Professor, Vaccine Research Institute of San Diego
• Group Head, Valneva SE
• Strategic Market Research Analyst, Varian Medical Systems Inc
• Medical Oncologist, Vilnius University
• Journalist, VJHemOnc
• Study Director, VOXCAN
• CEO, Vyriad
• Principal Investigator, Weizmann Institute Of Science
• Group Leader, Xencor Inc